K

KK Shah Hospitals Limited

KKSHL
Market snapshot · 2026-08-12 15:34 UTC

43.90

+₹3.90 (+9.75%)

MARKET CAP

₹29.89 Cr

STOCK P/E

52W HIGH

₹51.90

52W LOW

₹29.00

BOOK VALUE

₹18.79

EPS

₹-0.91

ROE

-4.75%

SECTOR

Health Care

DEBT/EQUITY

VOLUME

3,000

P/B RATIO

2.34x

PEG RATIO

Sector

Health Care

Themes

Hospitals & Diagnostic Centres
₹48.10₹44.29₹40.48₹36.66₹32.85VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

EV/EBITDA
Strongly Undervalued

5Y Average

36.73

Current

34.78

Overvalued

38.42

Undervalued

33.19

P/S
Undervalued

5Y Average

3.35

Current

3.17

Overvalued

3.85

Undervalued

2.85

P/B
Fair

5Y Average

2.17

Current

2.34

Overvalued

2.49

Undervalued

1.84

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹4.61 CrMar 2026

Latest net profit

₹-0.30 CrMar 2026

Latest EPS

₹-0.44Mar 2026

Net margin

2.6%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-5.0%0.0%5.0%10.0%15.0%-2.00 Cr0.00 Cr2.00 Cr4.00 Cr6.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr2.00 Cr4.00 Cr6.00 Cr8.00 Cr₹-1₹-1₹-1₹-1₹-0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherOtheradjustmentsNet Profit-2.00 Cr0.00 Cr2.00 Cr4.00 Cr6.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Debt free
Mar 2023Mar 2024Mar 2025Mar 2026-6.00 Cr0.00 Cr6.00 Cr12 Cr18 Cr
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales +2.123.393.494.034.974.824.61
Expenses +1.753.013.273.705.184.174.49
Operating Profit0.370.380.220.33-0.210.650.12
OPM %17.45%11.21%6.30%8.19%-4.23%13.49%2.60%
Other Income +0.020.130.350.180.380.040.15
Interest0.000.000.000.000.000.000.00
Depreciation0.100.190.190.350.660.910.78
Profit before tax0.290.320.380.16-0.49-0.22-0.51
Tax %24.14%25.00%2.63%-131.25%44.90%45.45%-41.18%
Net Profit +0.220.240.370.37-0.70-0.32-0.30
EPS in Rs0.450.490.540.54-1.03-0.47-0.44
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderMar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Promoters +71.36%71.36%71.36%71.36%71.36%
Public +28.65%28.63%28.64%28.63%28.65%
Others0.01%0.01%
Mar 2026
Promoters +
Public +

Events Timeline

Notice Of Shareholder Meeting On August 18, 2026

Jul 25, 2026PDFCompany Reports Open

Reg. 34 (1) Annual Report.

Jul 25, 2026PDFCompany Reports Open

Board Meeting Outcome

Jul 24, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 13, 2026PDFCompany Reports Open

Installation And Commissioning Of GE Revolution Evo 64-Slice Cardiac CT Scanner.

Jul 01, 2026PDFCompany Reports Open